Author: Kai Duan; Bende Liu; Cesheng Li; Huajun Zhang; Ting Yu; Jieming Qu; Min Zhou; Li Chen; Shengli Meng; Yong Hu; Cheng Peng; Mingchao Yuan; Jinyan Huang; Zejun Wang; Jianhong Yu; Xiaoxiao Gao; Dan Wang; Xiaoqi Yu; Li Li; Jiayou Zhang; Xiao Wu; Bei Li; Yanping Yu; Wei Chen; Yan Peng; Yeqin Hu; Lianzhen Lin; Xuefei Liu; Shihe Huang; Zhijun Zhou; Lianghao Zhang; Yue Wang; Zhi Zhang; Kun Deng; Zhiwu Xia; Qin Gong; Wei Zhang; Xiaobei Zheng; Ying Liu; Huichuan Yang; Dongbo Zhou; Ding Yu; Jifeng Hou; Zhengli Shi; Saijuan Chen; Zhu Chen; Xin-xin Zhang; Xiaoming Yang
Title: The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study Document date: 2020_3_23
ID: 8znnq0rh_37
Snippet: In the present study, no severe adverse effects were observed. One of the risks of plasma transfusion is the transmission of the potential pathogen. Methylene blue photochemistry was applied in this study to inactivate the potential residual virus and to maintain the activity of neutralizing antibodies as much as possible, a method known to be much better than ultraviolet C light (25) . No specific virus was detected before transfusion. Transfusi.....
Document: In the present study, no severe adverse effects were observed. One of the risks of plasma transfusion is the transmission of the potential pathogen. Methylene blue photochemistry was applied in this study to inactivate the potential residual virus and to maintain the activity of neutralizing antibodies as much as possible, a method known to be much better than ultraviolet C light (25) . No specific virus was detected before transfusion. Transfusion-related acute lung injury (TRALI) was reported in an Ebola virus disease woman who received CP therapy (26) . Although uncommon in the general population receiving plasma transfusion, this specific adverse reaction is worth noting, especially among critically illed patients experiencing significant pulmonary injury (27) .
Search related documents:
Co phrase search for related documents- acute lung injury and adverse reaction: 1
- acute lung injury and CP therapy: 1
- acute lung injury and disease woman: 1
- acute lung injury and Ebola virus: 1, 2
- acute lung injury and general population: 1, 2, 3, 4
- acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and plasma transfusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute lung injury and plasma transfusion risk: 1, 2
- adverse effect and general population: 1, 2, 3, 4, 5, 6, 7, 8
- adverse effect and lung injury: 1, 2, 3
- adverse effect and plasma transfusion: 1, 2, 3, 4
- adverse effect and plasma transfusion risk: 1
- adverse reaction and disease woman: 1
- adverse reaction and general population: 1, 2, 3, 4, 5, 6
- adverse reaction and lung injury: 1, 2
- adverse reaction and plasma transfusion: 1, 2
- CP therapy and plasma transfusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- CP therapy and plasma transfusion receive: 1
- CP therapy and plasma transfusion risk: 1
Co phrase search for related documents, hyperlinks ordered by date